杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/06/10 | 1,603 | 1,603 | 1,565 | 1,571 | -21 | -1.3% | 238,000 |
| 2011/06/09 | 1,563 | 1,592 | 1,563 | 1,592 | +25 | +1.6% | 197,000 |
| 2011/06/08 | 1,550 | 1,570 | 1,547 | 1,567 | +17 | +1.1% | 94,000 |
| 2011/06/07 | 1,540 | 1,550 | 1,540 | 1,550 | +10 | +0.6% | 124,000 |
| 2011/06/06 | 1,538 | 1,544 | 1,528 | 1,540 | +2 | +0.1% | 129,000 |
| 2011/06/03 | 1,534 | 1,541 | 1,517 | 1,538 | +3 | +0.2% | 257,000 |
| 2011/06/02 | 1,534 | 1,541 | 1,526 | 1,535 | -10 | -0.6% | 108,000 |
| 2011/06/01 | 1,530 | 1,545 | 1,526 | 1,545 | +15 | +1% | 187,000 |
| 2011/05/31 | 1,545 | 1,547 | 1,530 | 1,530 | -14 | -0.9% | 271,000 |
| 2011/05/30 | 1,530 | 1,545 | 1,520 | 1,544 | +7 | +0.5% | 86,000 |
| 2011/05/27 | 1,543 | 1,545 | 1,534 | 1,537 | -8 | -0.5% | 114,000 |
| 2011/05/26 | 1,550 | 1,564 | 1,541 | 1,545 | -8 | -0.5% | 193,000 |
| 2011/05/25 | 1,550 | 1,555 | 1,530 | 1,553 | +23 | +1.5% | 221,000 |
| 2011/05/24 | 1,506 | 1,530 | 1,500 | 1,530 | +24 | +1.6% | 147,000 |
| 2011/05/23 | 1,493 | 1,514 | 1,484 | 1,506 | +13 | +0.9% | 215,000 |
| 2011/05/20 | 1,489 | 1,508 | 1,485 | 1,493 | -15 | -1% | 182,000 |
| 2011/05/19 | 1,488 | 1,516 | 1,480 | 1,508 | +20 | +1.3% | 294,000 |
| 2011/05/18 | 1,484 | 1,502 | 1,484 | 1,488 | +3 | +0.2% | 122,000 |
| 2011/05/17 | 1,484 | 1,491 | 1,479 | 1,485 | +9 | +0.6% | 171,000 |
| 2011/05/16 | 1,464 | 1,489 | 1,464 | 1,476 | -3 | -0.2% | 111,000 |
| 2011/05/13 | 1,506 | 1,506 | 1,473 | 1,479 | -19 | -1.3% | 129,000 |
| 2011/05/12 | 1,488 | 1,511 | 1,474 | 1,498 | +8 | +0.5% | 274,000 |
| 2011/05/11 | 1,500 | 1,500 | 1,471 | 1,490 | +3 | +0.2% | 149,000 |
| 2011/05/10 | 1,489 | 1,494 | 1,484 | 1,487 | ±0 | ±0% | 108,000 |
| 2011/05/09 | 1,494 | 1,501 | 1,483 | 1,487 | +3 | +0.2% | 199,000 |
| 2011/05/06 | 1,479 | 1,492 | 1,477 | 1,484 | +5 | +0.3% | 162,000 |
| 2011/05/02 | 1,449 | 1,485 | 1,445 | 1,479 | +34 | +2.4% | 211,000 |
| 2011/04/28 | 1,409 | 1,447 | 1,405 | 1,445 | +43 | +3.1% | 191,000 |
| 2011/04/27 | 1,405 | 1,415 | 1,388 | 1,402 | -3 | -0.2% | 198,000 |
| 2011/04/26 | 1,423 | 1,423 | 1,398 | 1,405 | -18 | -1.3% | 152,000 |
| 2011/04/25 | 1,452 | 1,455 | 1,419 | 1,423 | +1 | +0.1% | 168,000 |
| 2011/04/22 | 1,422 | 1,431 | 1,419 | 1,422 | +1 | +0.1% | 139,000 |
| 2011/04/21 | 1,422 | 1,426 | 1,413 | 1,421 | +1 | +0.1% | 99,000 |
| 2011/04/20 | 1,406 | 1,434 | 1,406 | 1,420 | +16 | +1.1% | 95,000 |
| 2011/04/19 | 1,401 | 1,414 | 1,400 | 1,404 | -16 | -1.1% | 98,000 |
| 2011/04/18 | 1,433 | 1,440 | 1,418 | 1,420 | -5 | -0.4% | 100,000 |
| 2011/04/15 | 1,415 | 1,432 | 1,410 | 1,425 | +15 | +1.1% | 193,000 |
| 2011/04/14 | 1,404 | 1,419 | 1,391 | 1,410 | +2 | +0.1% | 147,000 |
| 2011/04/13 | 1,398 | 1,414 | 1,398 | 1,408 | +8 | +0.6% | 54,000 |
| 2011/04/12 | 1,403 | 1,414 | 1,395 | 1,400 | -16 | -1.1% | 119,000 |
| 2011/04/11 | 1,415 | 1,424 | 1,397 | 1,416 | +18 | +1.3% | 231,000 |
| 2011/04/08 | 1,372 | 1,409 | 1,371 | 1,398 | +27 | +2% | 167,000 |
| 2011/04/07 | 1,370 | 1,388 | 1,364 | 1,371 | +3 | +0.2% | 233,000 |
| 2011/04/06 | 1,401 | 1,404 | 1,362 | 1,368 | -22 | -1.6% | 296,000 |
| 2011/04/05 | 1,406 | 1,408 | 1,379 | 1,390 | -9 | -0.6% | 154,000 |
| 2011/04/04 | 1,402 | 1,412 | 1,393 | 1,399 | -10 | -0.7% | 163,000 |
| 2011/04/01 | 1,422 | 1,430 | 1,401 | 1,409 | -7 | -0.5% | 181,000 |
| 2011/03/31 | 1,418 | 1,418 | 1,402 | 1,416 | +2 | +0.1% | 165,000 |
| 2011/03/30 | 1,388 | 1,414 | 1,381 | 1,414 | +16 | +1.1% | 207,000 |
| 2011/03/29 | 1,413 | 1,413 | 1,387 | 1,398 | -15 | -1.1% | 192,000 |
3401～
3450
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
